These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 16162105
1. Prevention of chronic allograft nephropathy with vitamin D. Hullett DA, Laeseke PF, Malin G, Nessel R, Sollinger HW, Becker BN. Transpl Int; 2005 Oct; 18(10):1175-86. PubMed ID: 16162105 [Abstract] [Full Text] [Related]
2. Protective effects of atorvastatin on chronic allograft nephropathy in rats. Zhang W, Liu M, Wu Y, Zhu P, Yin C, Zhang W, Gu M. J Surg Res; 2007 Dec; 143(2):428-36. PubMed ID: 17628598 [Abstract] [Full Text] [Related]
3. The effect of combined rapamycin/cyclosporine on the changes in pro-fibrotic gene expression that occur during the development of allograft vasculopathy in rats, compared with cyclosporine or rapamycin in isolation. Murphy GJ, Bicknell GR, Nicholson ML. Transpl Int; 2003 May; 16(5):347-53. PubMed ID: 12759727 [Abstract] [Full Text] [Related]
4. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression. Rintala JM, Savikko J, Rintala SE, von Willebrand E. Transplant Proc; 2006 Dec; 38(10):3239-40. PubMed ID: 17175234 [Abstract] [Full Text] [Related]
5. The effects of different immunosuppressants on chronic allograft nephropathy by affecting the transforming growth factor-beta and Smads signal pathways. Gao R, Lu Y, Xin YP, Zhang XH, Wang J, Li YP. Transplant Proc; 2006 Sep; 38(7):2154-7. PubMed ID: 16980029 [Abstract] [Full Text] [Related]
6. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine. Roos M, Liu S, Strobl M, Schmaderer C, Baumann M, Heemann U, Lutz J. Transplant Proc; 2008 Dec; 40(10):3731-6. PubMed ID: 19100477 [Abstract] [Full Text] [Related]
7. Marrow Mesenchymal Stem Cells Effectively Reduce Histologic Changes in a Rat Model of Chronic Renal Allograft Rejection. Yu P, Wang Z, Liu Y, Xiao Z, Guo Y, Li M, Zhao M. Transplant Proc; 2017 Nov; 49(9):2194-2203. PubMed ID: 29149982 [Abstract] [Full Text] [Related]
8. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts. Rintala JM, Savikko J, Rintala SE, von Willebrand E. Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624 [Abstract] [Full Text] [Related]
9. Therapeutic effect of Y-27632 on chronic allograft nephropathy in rats. Liu M, Gu M, Wu Y, Zhu P, Zhang W, Yin C, Zhang WJ. J Surg Res; 2009 Nov; 157(1):e117-27. PubMed ID: 19589538 [Abstract] [Full Text] [Related]
10. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts. Pan F, Ebbs A, Wynn C, Erickson L, Jang MS, Crews G, Fisniku O, Kobayashi M, Paul LC, Benediktsson H, Jiang AH. Transplantation; 2003 Apr 27; 75(8):1110-4. PubMed ID: 12717186 [Abstract] [Full Text] [Related]
11. [Expression of matrix metalloproteinase-9 in renal tissues of rats with chronic allograft nephropathy at early stage and the role thereof]. Zou HQ, Yao J, Wang YX, Wang J, Li D, Wang P. Zhonghua Yi Xue Za Zhi; 2005 Apr 13; 85(14):981-5. PubMed ID: 16061007 [Abstract] [Full Text] [Related]
12. Do alloreactivity and prolonged cold ischemia cause different elementary lesions in chronic allograft nephropathy? Herrero-Fresneda I, Torras J, Cruzado JM, Condom E, Vidal A, Riera M, Lloberas N, Alsina J, Grinyo JM. Am J Pathol; 2003 Jan 13; 162(1):127-37. PubMed ID: 12507896 [Abstract] [Full Text] [Related]
13. CXC Chemokine Receptor Type 4 Antagonism Ameliorated Allograft Fibrosis in Rat Kidney Transplant Model. Zou XF, Gu JH, Cui ZL, Lu YW, Gu C. Exp Clin Transplant; 2017 Aug 13; 15(4):448-452. PubMed ID: 28585910 [Abstract] [Full Text] [Related]
14. 1 alpha,25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts. Redaelli CA, Wagner M, Tien YH, Mazzucchelli L, Stahel PF, Schilling MK, Dufour JF. Hepatology; 2001 Nov 13; 34(5):926-34. PubMed ID: 11679963 [Abstract] [Full Text] [Related]
15. Conversion from cyclosporin A to sirolimus retards the progression of chronic allograft nephropathy in the long term in a rat kidney transplantation model. He Z, Chen L, Qiu J, Li J, Zhao D, Chen G, Wang C. J Int Med Res; 2009 Nov 13; 37(5):1396-410. PubMed ID: 19930844 [Abstract] [Full Text] [Related]
16. Podocyte injury is suppressed by 1,25-dihydroxyvitamin D via modulation of transforming growth factor-beta 1/bone morphogenetic protein-7 signalling in puromycin aminonucleoside nephropathy rats. Xiao HQ, Shi W, Liu SX, Zhang B, Xu LX, Liang XL, Liang YZ. Clin Exp Pharmacol Physiol; 2009 Jul 13; 36(7):682-9. PubMed ID: 19594554 [Abstract] [Full Text] [Related]
17. Infections and reduced functioning kidney mass induce chronic rejection in rat kidney allografts. Heemann UW, Azuma H, Tullius SG, Schmid C, Philipp T, Tilney NL. Clin Nephrol; 1996 Jul 13; 46(1):34-8. PubMed ID: 8832148 [Abstract] [Full Text] [Related]
18. Ultrastructural analysis of the Fisher to Lewis rat model of chronic allograft nephropathy. Hamar P, Lipták P, Heemann U, Iványi B. Transpl Int; 2005 Jul 13; 18(7):863-70. PubMed ID: 15948867 [Abstract] [Full Text] [Related]
19. PG490-88, a new immunosuppressant, effectively prevents acute and chronic rejection in rat renal allografts. Pan F, Fisniku O, Wynn C, Erickson LM, Crews G, Jang MS, Sudo Y, Tamura K, Kobayashi M, Benediktsson H, Jiang H. Transplant Proc; 2005 Jul 13; 37(1):134-6. PubMed ID: 15808572 [Abstract] [Full Text] [Related]
20. Early short-term platelet-derived growth factor inhibition prevents the development of chronic allograft nephropathy in experimental rat kidney transplantation. Savikko J, Rintala J, von Willebrand E. Transplant Proc; 2006 Dec 13; 38(10):3231-2. PubMed ID: 17175231 [Abstract] [Full Text] [Related] Page: [Next] [New Search]